©The Author(s) 2020.
World J Diabetes. Dec 15, 2020; 11(12): 644-653
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.644
Published online Dec 15, 2020. doi: 10.4239/wjd.v11.i12.644
Table 2 Laboratory findings in patients diagnosed with or without diabetes (n = 61)
| Total | Diabetes | P value | |||
| No | Yes | ||||
| Sample, n (%) | 61 (100) | 46 (75.4) | 15 (24.6) | ||
| Routine blood parameters, n (%) | |||||
| Normal | 54 (88.5) | 42 (91.3) | 12 (80.0) | 0.399 | |
| Hemoglobin | 1 (1.6) | 0 (0.0) | 1 (6.7) | ||
| Neutrophil% | 3 (4.9) | 2 (4.3) | 1 (6.7) | ||
| Lymphocytes count | 3 (4.9) | 2 (4.3) | 1 (6.7) | ||
| Platelets count | 2 (3.3) | 2 (4.3) | 0 (0.0) | ||
| CRP, n (%) | |||||
| Normal | 49 (80.3) | 37 (80.4) | 12 (80.0) | 1 | |
| Abnormal | 12 (19.7) | 9 (19.6) | 3 (20.0) | ||
| ESR, n (%) | |||||
| Normal | 54 (88.5) | 39 (84.8) | 15 (100.0) | 0.178 | |
| Abnormal | 7 (11.5) | 7 (15.2) | 0 (0.0) | ||
| Hepatic dysfunction, n (%) | |||||
| No | 35 (57.4) | 29 (63.0) | 6 (40.0) | ||
| Yes | 26 (42.6) | 17 (37.0) | 9 (60.0) | 0.142 | |
| ALT or AST (%) | |||||
| Normal | 43 (70.5) | 34 (73.9) | 9 (60.0) | 0.34 | |
| Abnormal | 18 (29.5) | 12 (26.1) | 6 (40.0) | ||
| Bilirubin (%) | |||||
| Normal | 53 (86.9) | 39 (84.8) | 14 (93.3) | 0.666 | |
| Abnormal | 8 (13.1) | 7 (15.2) | 1 (6.7) | ||
| Albumin (%) | |||||
| Normal | 57 (93.4) | 45 (97.8) | 12 (80.0) | 0.043 | |
| Abnormal | 4 (6.6) | 1 (2.2) | 3 (20.0) | ||
| Other (%) | |||||
| Normal | 57 (93.4) | 43 (93.4) | 14 (93.3) | 0.687 | |
| Abnormal | 4 (6.6) | 3 (6.6) | 1 (6.7) | ||
- Citation: Xu M, Yang W, Huang T, Zhou J. Diabetic patients with COVID-19 need more attention and better glycemic control. World J Diabetes 2020; 11(12): 644-653
- URL: https://www.wjgnet.com/1948-9358/full/v11/i12/644.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i12.644